Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells
- PMID: 17105274
- DOI: 10.1021/ja0645943
Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells
Abstract
We have synthesized a series of MCM-41-type mesoporous silica nanoparticles (MSN). The surface of the MSNs are functionalized with 3-aminopropyl (AP), 3-guanidinopropyl (GP), 3-[N-(2-guanidinoethyl)guanidino]propyl (GEGP), and N-folate-3-aminopropyl (FAP). In contrast to the zeta-potential of -18.4 mV for FITC-MSN, the values of zeta-potential for AP-, GP-, GEGP-, and FAP-functionalized FITC-MSNs in 100 mM PBS buffer (pH 7.4) increased positively from -11.3, -10.6, -4.0, to +4.9 mV, respectively. The uptake efficiency, endocytosis mechanism, and biocompatibility of these organically functionalized MSNs were investigated with human cervical cancer cells (HeLa). Flow cytometry results suggested that the endocytosis of MSN could be manipulated by different surface functionalization. The immunocytochemistry study indicated that the uptake of these MSNs by HeLa cells was surface functional group dependent and involved several different mechanisms of endocytosis. Confocal fluorescence micrographs showed that the different surface functionalities of MSNs could also affect their ability to escape endosomal entrapment, which is a key factor in designing effective intracellular delivery vehicles.
Similar articles
-
Tuning the cellular uptake and cytotoxicity properties of oligonucleotide intercalator-functionalized mesoporous silica nanoparticles with human cervical cancer cells HeLa.Biomaterials. 2010 Feb;31(6):1325-33. doi: 10.1016/j.biomaterials.2009.11.009. Epub 2009 Nov 24. Biomaterials. 2010. PMID: 19932923
-
Mesoporosity and functional group dependent endocytosis and cytotoxicity of silica nanomaterials.Chem Res Toxicol. 2009 Nov;22(11):1869-80. doi: 10.1021/tx900276u. Chem Res Toxicol. 2009. PMID: 19817448
-
PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.Nanoscale. 2011 Aug;3(8):3198-207. doi: 10.1039/c1nr10253b. Epub 2011 Jul 4. Nanoscale. 2011. PMID: 21725561
-
Mesoporous silica nanoparticles for intracellular controlled drug delivery.Small. 2010 Sep 20;6(18):1952-67. doi: 10.1002/smll.200901789. Small. 2010. PMID: 20690133 Review.
-
Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges.Nanoscale. 2010 Oct;2(10):1870-83. doi: 10.1039/c0nr00156b. Epub 2010 Aug 23. Nanoscale. 2010. PMID: 20730166 Review.
Cited by
-
Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.Theranostics. 2020 Aug 2;10(21):9808-9829. doi: 10.7150/thno.43631. eCollection 2020. Theranostics. 2020. PMID: 32863961 Free PMC article.
-
Silica-Based Gene Delivery Systems: From Design to Therapeutic Applications.Pharmaceutics. 2020 Jul 9;12(7):649. doi: 10.3390/pharmaceutics12070649. Pharmaceutics. 2020. PMID: 32660110 Free PMC article. Review.
-
Cytotoxicological pathways induced after nanoparticle exposure: studies of oxidative stress at the 'nano-bio' interface.Toxicol Res (Camb). 2017 Jul 13;6(5):580-594. doi: 10.1039/c7tx00119c. eCollection 2017 Sep 1. Toxicol Res (Camb). 2017. PMID: 30090527 Free PMC article. Review.
-
Mesoporous Silica-Based Nanoplatforms Are Theranostic Agents for the Treatment of Inflammatory Disorders.Pharmaceutics. 2023 Jan 28;15(2):439. doi: 10.3390/pharmaceutics15020439. Pharmaceutics. 2023. PMID: 36839761 Free PMC article. Review.
-
The emergence of nanoporous materials in lung cancer therapy.Sci Technol Adv Mater. 2022 Jul 20;23(1):225-274. doi: 10.1080/14686996.2022.2052181. eCollection 2022. Sci Technol Adv Mater. 2022. PMID: 35875329 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous